From implementing KNN, PCA, and clustering to applying deep learning and scientific tuning, these resources show how to build, refine, and optimize machine learning models. They combine hands-on ...

Data science is one of the most in-demand skills in 2026, and a clear learning path can take you from beginner to expert. With structured roadmaps, hands-on projects, and industry-recognized ...

Proper waste sorting is very important for keeping our neighbourhoods clean and saving resources for the future. When we mix ...

VELDHOVEN, the Netherlands—Big tech companies are gearing up to spend hundreds of billions of dollars on artificial-intelligence infrastructure. Their plans depend on a one-of-a-kind Dutch equipment ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

The rapid acceleration of AI adoption across industries is reshaping not only products, but also the engineering roles that support them. As organizations move machine learning systems from ...

Machine learning is an essential component of artificial intelligence. Whether it’s powering recommendation engines, fraud detection systems, self-driving cars, generative AI, or any of the countless ...

Artificial intelligence (AI) data center construction is booming—but its biggest name isn’t automatically the best investment. Meanwhile, a slower-growing tech sector is proving highly profitable for ...

CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle”) is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: ...

Applied Digital boasts an exceptionally strong long-term demand visibility. The company is focused on rapidly expanding its data center capacity to meet surging demand. Applied Digital has also ...

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.